Evidence map›Paper›PMID 23555248›Full record

ArticlePLoS pathogens2013

TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine.

Stephanie Jemielity, Jinyize J Wang, Ying Kai Chan, Asim A Ahmed, Wenhui Li, Sheena Monahan, Xia Bu, Michael Farzan, Gordon J Freeman, Dale T Umetsu and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 233 papers.

0numbers the graph read from it
0cells of the map it votes in
233citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

233 citing papers in PubMed, 345 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cellular Biology: Virus-Host Interactions and RNA Structure and Function.Current topics in microbiology and immunology · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

173 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Stephanie JemielityDivision of Respiratory Diseases Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America.
Jinyize J Wang
Ying Kai Chan
Asim A Ahmed
Wenhui Li
Sheena Monahan
Xia Bu
Michael Farzan
Gordon J Freeman
Dale T Umetsu
Rosemarie H Dekruyff
Hyeryun Choe
Boston Children's Hospital · USHarvard University · USDana-Farber Cancer Institute · USNew England Biolabs (United States) · USNational Institute of Biological Sciences, Beijing · CN

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KASPER, DENNIS L. · 2003 to 2013
$113.7M
TIM recognition of phosphatidylserine regulates innate and adaptive immunityP01AI054456 · NIAID · STANFORD UNIVERSITY · PI CASASNOVAS, JOSE M · 2003 to 2014
$12.8M
A Cellular Receptor for New World ArenavirusesR01AI074879 · NIAID · SCRIPPS FLORIDA · PI CHOE, HYERYUN · 2007 to 2014
$3.4M
TIM recognition of PtdSer on apoptotic cells and the regulation of immunityR01AI089955 · NIAID · DANA-FARBER CANCER INST · PI DEKRUYFF, ROSEMARIE H, FREEMAN, GORDON JAMES · 2010 to 2014
$2.1M
Viral and Host Determinants of New World Alphaviral EntryK08AI093676 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI AHMED, ASIM AMINSHARIF · 2011 to 2015
$668k
NIAID NIH HHS AI054456NIAID NIH HHS AI057159NIAID NIH HHS AI074879NIAID NIH HHS AI089955NIAID NIH HHS K08 AI093676NIAID NIH HHS P01 AI054456NIAID NIH HHS R01 AI074879NIAID NIH HHS R01 AI089955NIAID NIH HHS U54 AI057159
6 · The paper itself

Abstract

Human T-cell Immunoglobulin and Mucin-domain containing proteins (TIM1, 3, and 4) specifically bind phosphatidylserine (PS). TIM1 has been proposed to serve as a cellular receptor for hepatitis A virus and Ebola virus and as an entry factor for dengue virus. Here we show that TIM1 promotes infection of retroviruses and virus-like particles (VLPs) pseudotyped with a range of viral entry proteins, in particular those from the filovirus, flavivirus, New World arenavirus and alphavirus families. TIM1 also robustly enhanced the infection of replication-competent viruses from the same families, including dengue, Tacaribe, Sindbis and Ross River viruses. All interactions between TIM1 and pseudoviruses or VLPs were PS-mediated, as demonstrated with liposome blocking and TIM1 mutagenesis experiments. In addition, other PS-binding proteins, such as Axl and TIM4, promoted infection similarly to TIM1. Finally, the blocking of PS receptors on macrophages inhibited the entry of Ebola VLPs, suggesting that PS receptors can contribute to infection in physiologically relevant cells. Notably, infection mediated by the entry proteins of Lassa fever virus, influenza A virus and SARS coronavirus was largely unaffected by TIM1 expression. Taken together our data show that TIM1 and related PS-binding proteins promote infection of diverse families of enveloped viruses, and may therefore be useful targets for broad-spectrum antiviral therapies.

Indexed as

Host-Pathogen InteractionsAnimalsAntiviral AgentsCapsidCell LineDogsGuanine Nucleotide Exchange FactorsHumansMacrophagesMicePhosphatidylserinesProto-Oncogene ProteinsReceptors, VirusRho Guanine Nucleotide Exchange FactorsViral Envelope ProteinsVirionAntiviral AgentsARHGEF5 protein, humanGuanine Nucleotide Exchange FactorsPhosphatidylserinesProto-Oncogene ProteinsReceptors, VirusRho Guanine Nucleotide Exchange FactorsViral Envelope Proteins

Identifiers

PMID23555248
PMCPMC3610696
OpenAlexW2122756910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.